Old Web
English
Sign In
Acemap
>
authorDetail
>
Patricia Lenhart
Patricia Lenhart
University of Colorado Boulder
Biology
Oncology
MEK inhibitor
Rash
Immunology
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Accelerated structural and functional loss of retinal ganglion cells in a transgenic mouse model of retinopathy
2019
Investigative Ophthalmology & Visual Science
J. Mark Petrash
Biehuoy Shieh
Michelle Pedler
Kun-Che Chang
Patricia Lenhart
David J. Orlicky
David A. Ammar
Show All
Source
Cite
Save
Citations (0)
Abstract A88: Safety, pharmacokinetic, and pharmacodynamic results of BAY 86–9766, an oral MEK inhibitor, in combination with sorafenib, an oral multikinase inhibitor, in advanced cancer patients.
2011
Molecular Cancer Therapeutics
Alex A. Adjei
Donald A. Richards
Anthony B. El-Khoueiry
Carlos Becerra
Joe Stephenson
Diane P. Leffingwell
Cory Iverson
Jeffrey N. Miner
Zancong Shen
Sonny Gunawan
David O. Wilson
Kimberly Manhard
Ron L. Dubowy
Michael Jeffers
Prabhu Rajagopalan
Wilbur A. Franklin
Jerry Haney
Patricia Lenhart
Neil J. Clendeninn
Show All
Source
Cite
Save
Citations (1)
1